APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase (HDAC) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Histone Deacetylase (HDAC) Inhibitors Market Analysis and Forecast 2026-2032

26 December 2025193 pages

Choose your research edition.

Industry ResearchHistone Deacetylase (HDAC) Inhibitors Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase (HDAC) Inhibitors Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase (HDAC) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase (HDAC) Inhibitors Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase (HDAC) Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Histone Deacetylase (HDAC) Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Histone Deacetylase (HDAC) Inhibitors include 4SC, Novartis, TetraLogic, Repligen, Onxeo, Mirati Therapeutics, MEI Pharma, Curis and CrystalGenomics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Histone Deacetylase (HDAC) Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Histone Deacetylase (HDAC) Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for Histone Deacetylase (HDAC) Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Histone Deacetylase (HDAC) Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Histone Deacetylase (HDAC) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Histone Deacetylase (HDAC) Inhibitors sales, projected growth trends, production technology, application and end-user industry.

Histone Deacetylase (HDAC) Inhibitors Segment by Company

4SC

Novartis

TetraLogic

Repligen

Onxeo

Mirati Therapeutics

MEI Pharma

Curis

CrystalGenomics

Chroma Therapeutics

Chipscreen Biosciences

Celleron Therapeutics

Acetylon Pharmaceuticals

Histone Deacetylase (HDAC) Inhibitors Segment by Type

Benzamide

Cyclic Peptide

Hydroxamate

Fatty Acid

Histone Deacetylase (HDAC) Inhibitors Segment by Application

Treatment of Malignant Tumors

Chronic Disease Treatment

Others

Histone Deacetylase (HDAC) Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase (HDAC) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase (HDAC) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase (HDAC) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Histone Deacetylase (HDAC) Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Histone Deacetylase (HDAC) Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Histone Deacetylase (HDAC) Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Benzamide Major Manufacturers Table 3. Cyclic Peptide Major Manufacturers Table 4. Hydroxamate Major Manufacturers Table 5. Fatty Acid Major Manufacturers Table 6. Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Treatment of Malignant Tumors Major Manufacturers Table 8. Chronic Disease Treatment Major Manufacturers Table 9. Others Major Manufacturers Table 10. Histone Deacetylase (HDAC) Inhibitors Industry Trends Table 11. Histone Deacetylase (HDAC) Inhibitors Industry Drivers Table 12. Histone Deacetylase (HDAC) Inhibitors Industry Opportunities and Challenges Table 13. Histone Deacetylase (HDAC) Inhibitors Industry Restraints Table 14. Global Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2021-2026) Table 18. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2027-2032) Table 19. Global Histone Deacetylase (HDAC) Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 20. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2021-2026) & (Tons) Table 21. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2027-2032) & (Tons) Table 22. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2021-2026) Table 23. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2027-2032) Table 24. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Histone Deacetylase (HDAC) Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 28. Global Histone Deacetylase (HDAC) Inhibitors Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 29. Global Histone Deacetylase (HDAC) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Histone Deacetylase (HDAC) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Histone Deacetylase (HDAC) Inhibitors Manufacturers, Product Type & Application Table 32. Global Histone Deacetylase (HDAC) Inhibitors Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Histone Deacetylase (HDAC) Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2021-2026) Table 39. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2027-2032) Table 40. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 41. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2026) & (Tons) Table 42. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2027-2032) & (Tons) Table 43. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2021-2026) Table 44. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2027-2032) Table 45. Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2021-2026) & (US$/Ton) Table 46. Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2027-2032) & (US$/Ton) Table 47. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2021-2026) Table 51. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2027-2032) Table 52. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 53. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2026) & (Tons) Table 54. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2027-2032) & (Tons) Table 55. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2021-2026) Table 56. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2027-2032) Table 57. Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2021-2026) & (US$/Ton) Table 58. Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2027-2032) & (US$/Ton) Table 59. 4SC Company Information Table 60. 4SC Business Overview Table 61. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 62. 4SC Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 63. 4SC Recent Development Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Novartis Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 68. Novartis Recent Development Table 69. TetraLogic Company Information Table 70. TetraLogic Business Overview Table 71. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. TetraLogic Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 73. TetraLogic Recent Development Table 74. Repligen Company Information Table 75. Repligen Business Overview Table 76. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Repligen Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 78. Repligen Recent Development Table 79. Onxeo Company Information Table 80. Onxeo Business Overview Table 81. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Onxeo Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 83. Onxeo Recent Development Table 84. Mirati Therapeutics Company Information Table 85. Mirati Therapeutics Business Overview Table 86. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 88. Mirati Therapeutics Recent Development Table 89. MEI Pharma Company Information Table 90. MEI Pharma Business Overview Table 91. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 93. MEI Pharma Recent Development Table 94. Curis Company Information Table 95. Curis Business Overview Table 96. Curis Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Curis Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 98. Curis Recent Development Table 99. CrystalGenomics Company Information Table 100. CrystalGenomics Business Overview Table 101. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 103. CrystalGenomics Recent Development Table 104. Chroma Therapeutics Company Information Table 105. Chroma Therapeutics Business Overview Table 106. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 108. Chroma Therapeutics Recent Development Table 109. Chipscreen Biosciences Company Information Table 110. Chipscreen Biosciences Business Overview Table 111. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 113. Chipscreen Biosciences Recent Development Table 114. Celleron Therapeutics Company Information Table 115. Celleron Therapeutics Business Overview Table 116. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 118. Celleron Therapeutics Recent Development Table 119. Acetylon Pharmaceuticals Company Information Table 120. Acetylon Pharmaceuticals Business Overview Table 121. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Portfolio Table 123. Acetylon Pharmaceuticals Recent Development Table 124. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2026) & (Tons) Table 127. North America Histone Deacetylase (HDAC) Inhibitors Sales by Type (2027-2032) & (Tons) Table 128. North America Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2021-2026) & (US$/Ton) Table 129. North America Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2027-2032) & (US$/Ton) Table 130. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2026) & (Tons) Table 133. North America Histone Deacetylase (HDAC) Inhibitors Sales by Application (2027-2032) & (Tons) Table 134. North America Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2021-2026) & (US$/Ton) Table 135. North America Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2027-2032) & (US$/Ton) Table 136. North America Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. North America Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 140. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021-2026) & (Tons) Table 141. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2027-2032) & (Tons) Table 142. North America Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2021-2026) & (US$/Ton) Table 143. North America Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2027-2032) & (US$/Ton) Table 144. United States Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 145. Canada Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 146. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 147. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2026) & (Tons) Table 150. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Type (2027-2032) & (Tons) Table 151. Europe Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2021-2026) & (US$/Ton) Table 152. Europe Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2027-2032) & (US$/Ton) Table 153. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 154. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 155. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2026) & (Tons) Table 156. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Application (2027-2032) & (Tons) Table 157. Europe Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2021-2026) & (US$/Ton) Table 158. Europe Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2027-2032) & (US$/Ton) Table 159. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 163. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021-2026) & (Tons) Table 164. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2027-2032) & (Tons) Table 165. Europe Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2021-2026) & (US$/Ton) Table 166. Europe Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2027-2032) & (US$/Ton) Table 167. Germany Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 168. France Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 169. U.K. Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 170. Italy Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 171. Russia Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 172. Spain Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 173. Netherlands Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 174. Switzerland Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 175. Sweden Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 176. Poland Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 177. China Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 178. China Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 179. China Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2026) & (Tons) Table 180. China Histone Deacetylase (HDAC) Inhibitors Sales by Type (2027-2032) & (Tons) Table 181. China Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2021-2026) & (US$/Ton) Table 182. China Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2027-2032) & (US$/Ton) Table 183. China Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 184. China Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 185. China Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2026) & (Tons) Table 186. China Histone Deacetylase (HDAC) Inhibitors Sales by Application (2027-2032) & (Tons) Table 187. China Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2021-2026) & (US$/Ton) Table 188. China Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2027-2032) & (US$/Ton) Table 189. Asia Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 190. Asia Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 191. Asia Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2026) & (Tons) Table 192. Asia Histone Deacetylase (HDAC) Inhibitors Sales by Type (2027-2032) & (Tons) Table 193. Asia Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2021-2026) & (US$/Ton) Table 194. Asia Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2027-2032) & (US$/Ton) Table 195. Asia Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 196. Asia Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 197. Asia Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2026) & (Tons) Table 198. Asia Histone Deacetylase (HDAC) Inhibitors Sales by Application (2027-2032) & (Tons) Table 199. Asia Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2021-2026) & (US$/Ton) Table 200. Asia Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2027-2032) & (US$/Ton) Table 201. Asia Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Asia Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. Asia Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. Asia Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 205. Asia Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021-2026) & (Tons) Table 206. Asia Histone Deacetylase (HDAC) Inhibitors Sales by Country (2027-2032) & (Tons) Table 207. Asia Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2021-2026) & (US$/Ton) Table 208. Asia Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2027-2032) & (US$/Ton) Table 209. Japan Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 210. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 211. India Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 212. Australia Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 213. Taiwan Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 214. Southeast Asia Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 215. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 216. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 217. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2026) & (Tons) Table 218. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Type (2027-2032) & (Tons) Table 219. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2021-2026) & (US$/Ton) Table 220. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Price by Type (2027-2032) & (US$/Ton) Table 221. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 222. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 223. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2026) & (Tons) Table 224. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Application (2027-2032) & (Tons) Table 225. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2021-2026) & (US$/Ton) Table 226. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Price by Application (2027-2032) & (US$/Ton) Table 227. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 231. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021-2026) & (Tons) Table 232. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Country (2027-2032) & (Tons) Table 233. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2021-2026) & (US$/Ton) Table 234. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Price by Country (2027-2032) & (US$/Ton) Table 235. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 236. Argentina Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 237. Chile Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 238. Colombia Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 239. Peru Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 240. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 241. Israel Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 242. UAE Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 243. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 244. Iran Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 245. Egypt Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Histone Deacetylase (HDAC) Inhibitors Distributors List Table 249. Histone Deacetylase (HDAC) Inhibitors Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Histone Deacetylase (HDAC) Inhibitors Image Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase (HDAC) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. Benzamide Image Figure 5. Cyclic Peptide Image Figure 6. Hydroxamate Image Figure 7. Fatty Acid Image Figure 8. Global Histone Deacetylase (HDAC) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Histone Deacetylase (HDAC) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 10. Treatment of Malignant Tumors Image Figure 11. Chronic Disease Treatment Image Figure 12. Others Image Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 15. Global Histone Deacetylase (HDAC) Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2021-2032) Figure 18. Global Histone Deacetylase (HDAC) Inhibitors Sales (2021-2032) & (Tons) Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 20. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Histone Deacetylase (HDAC) Inhibitors Sales YoY (2021-2032) & (Tons) Figure 22. Europe Histone Deacetylase (HDAC) Inhibitors Sales YoY (2021-2032) & (Tons) Figure 23. China Histone Deacetylase (HDAC) Inhibitors Sales YoY (2021-2032) & (Tons) Figure 24. Asia (Excluding China) Histone Deacetylase (HDAC) Inhibitors Sales YoY (2021-2032) & (Tons) Figure 25. South America, Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales YoY (2021-2032) & (Tons) Figure 26. Global Histone Deacetylase (HDAC) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Histone Deacetylase (HDAC) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2021-2032) Figure 32. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 33. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2021-2032) Figure 35. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2021-2032) Figure 38. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 39. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2021-2032) Figure 41. North America Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2021-2032) Figure 42. North America Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2021-2032) Figure 43. North America Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2021-2032) Figure 44. North America Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2021-2032) Figure 45. North America Histone Deacetylase (HDAC) Inhibitors Revenue Share by Country (2021-2032) Figure 46. North America Histone Deacetylase (HDAC) Inhibitors Sales Share by Country (2021-2032) Figure 47. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2021-2032) Figure 48. Europe Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2021-2032) Figure 49. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2021-2032) Figure 50. Europe Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2021-2032) Figure 51. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Share by Country (2021-2032) Figure 52. Europe Histone Deacetylase (HDAC) Inhibitors Sales Share by Country (2021-2032) Figure 53. China Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2021-2032) Figure 54. China Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2021-2032) Figure 55. China Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2021-2032) Figure 56. China Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2021-2032) Figure 57. Asia Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2021-2032) Figure 58. Asia Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2021-2032) Figure 59. Asia Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2021-2032) Figure 60. Asia Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2021-2032) Figure 61. Asia Histone Deacetylase (HDAC) Inhibitors Revenue Share by Country (2021-2032) Figure 62. Asia Histone Deacetylase (HDAC) Inhibitors Sales Share by Country (2021-2032) Figure 63. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue Share by Type (2021-2032) Figure 64. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Share by Type (2021-2032) Figure 65. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue Share by Application (2021-2032) Figure 66. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Share by Application (2021-2032) Figure 67. SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue Share by Country (2021-2032) Figure 68. SAMEA Histone Deacetylase (HDAC) Inhibitors Sales Share by Country (2021-2032) Figure 69. Histone Deacetylase (HDAC) Inhibitors Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Histone Deacetylase (HDAC) Inhibitors Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Benzamide
  • Cyclic Peptide
  • Hydroxamate
  • Fatty Acid
Applications
  • Treatment of Malignant Tumors
  • Chronic Disease Treatment
  • Others
Companies covered
  • 4SC
  • Novartis
  • TetraLogic
  • Repligen
  • Onxeo
  • Mirati Therapeutics
  • MEI Pharma
  • Curis
  • CrystalGenomics
  • Chroma Therapeutics
  • Chipscreen Biosciences
  • Celleron Therapeutics
  • Acetylon Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Histone Deacetylase (HDAC) Inhibitors Market by Type
  3. 1.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Benzamide
  5. 1.2.3 Cyclic Peptide
  6. 1.2.4 Hydroxamate
  7. 1.2.5 Fatty Acid
  8. 1.3 Histone Deacetylase (HDAC) Inhibitors Market by Application
  9. 1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Treatment of Malignant Tumors
  11. 1.3.3 Chronic Disease Treatment
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Histone Deacetylase (HDAC) Inhibitors Market Dynamics
  1. 2.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends
  2. 2.2 Histone Deacetylase (HDAC) Inhibitors Industry Drivers
  3. 2.3 Histone Deacetylase (HDAC) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase (HDAC) Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region
  3. 3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region
  9. 3.4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Histone Deacetylase (HDAC) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Manufacturers
  6. 4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Histone Deacetylase (HDAC) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Histone Deacetylase (HDAC) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Histone Deacetylase (HDAC) Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global Histone Deacetylase (HDAC) Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Histone Deacetylase (HDAC) Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 Histone Deacetylase (HDAC) Inhibitors Tier 1, Tier 2, and Tier 3
5 Histone Deacetylase (HDAC) Inhibitors Market by Type
  1. 5.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type
  2. 5.1.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type
  6. 5.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Type
6 Histone Deacetylase (HDAC) Inhibitors Market by Application
  1. 6.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application
  2. 6.1.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application
  6. 6.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Application
7 Company Profiles
  1. 7.1 4SC
  2. 7.1.1 4SC Company Information
  3. 7.1.2 4SC Business Overview
  4. 7.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  6. 7.1.5 4SC Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 TetraLogic
  14. 7.3.1 TetraLogic Company Information
  15. 7.3.2 TetraLogic Business Overview
  16. 7.3.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  18. 7.3.5 TetraLogic Recent Developments
  19. 7.4 Repligen
  20. 7.4.1 Repligen Company Information
  21. 7.4.2 Repligen Business Overview
  22. 7.4.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Repligen Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  24. 7.4.5 Repligen Recent Developments
  25. 7.5 Onxeo
  26. 7.5.1 Onxeo Company Information
  27. 7.5.2 Onxeo Business Overview
  28. 7.5.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  30. 7.5.5 Onxeo Recent Developments
  31. 7.6 Mirati Therapeutics
  32. 7.6.1 Mirati Therapeutics Company Information
  33. 7.6.2 Mirati Therapeutics Business Overview
  34. 7.6.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  36. 7.6.5 Mirati Therapeutics Recent Developments
  37. 7.7 MEI Pharma
  38. 7.7.1 MEI Pharma Company Information
  39. 7.7.2 MEI Pharma Business Overview
  40. 7.7.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  42. 7.7.5 MEI Pharma Recent Developments
  43. 7.8 Curis
  44. 7.8.1 Curis Company Information
  45. 7.8.2 Curis Business Overview
  46. 7.8.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Curis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  48. 7.8.5 Curis Recent Developments
  49. 7.9 CrystalGenomics
  50. 7.9.1 CrystalGenomics Company Information
  51. 7.9.2 CrystalGenomics Business Overview
  52. 7.9.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  54. 7.9.5 CrystalGenomics Recent Developments
  55. 7.10 Chroma Therapeutics
  56. 7.10.1 Chroma Therapeutics Company Information
  57. 7.10.2 Chroma Therapeutics Business Overview
  58. 7.10.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  60. 7.10.5 Chroma Therapeutics Recent Developments
  61. 7.11 Chipscreen Biosciences
  62. 7.11.1 Chipscreen Biosciences Company Information
  63. 7.11.2 Chipscreen Biosciences Business Overview
  64. 7.11.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  66. 7.11.5 Chipscreen Biosciences Recent Developments
  67. 7.12 Celleron Therapeutics
  68. 7.12.1 Celleron Therapeutics Company Information
  69. 7.12.2 Celleron Therapeutics Business Overview
  70. 7.12.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  72. 7.12.5 Celleron Therapeutics Recent Developments
  73. 7.13 Acetylon Pharmaceuticals
  74. 7.13.1 Acetylon Pharmaceuticals Company Information
  75. 7.13.2 Acetylon Pharmaceuticals Business Overview
  76. 7.13.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Portfolio
  78. 7.13.5 Acetylon Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Type
  2. 8.1.1 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America Histone Deacetylase (HDAC) Inhibitors Price by Type (2021-2032)
  5. 8.2 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Application
  6. 8.2.1 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America Histone Deacetylase (HDAC) Inhibitors Price by Application (2021-2032)
  9. 8.3 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Country
  10. 8.3.1 North America Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Histone Deacetylase (HDAC) Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Type
  2. 9.1.1 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe Histone Deacetylase (HDAC) Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Application
  6. 9.2.1 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe Histone Deacetylase (HDAC) Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Country
  10. 9.3.1 Europe Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Histone Deacetylase (HDAC) Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Histone Deacetylase (HDAC) Inhibitors Market Size by Type
  2. 10.1.1 China Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China Histone Deacetylase (HDAC) Inhibitors Price by Type (2021-2032)
  5. 10.2 China Histone Deacetylase (HDAC) Inhibitors Market Size by Application
  6. 10.2.1 China Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China Histone Deacetylase (HDAC) Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Histone Deacetylase (HDAC) Inhibitors Market Size by Type
  2. 11.1.1 Asia Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia Histone Deacetylase (HDAC) Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia Histone Deacetylase (HDAC) Inhibitors Market Size by Application
  6. 11.2.1 Asia Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia Histone Deacetylase (HDAC) Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia Histone Deacetylase (HDAC) Inhibitors Market Size by Country
  10. 11.3.1 Asia Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Histone Deacetylase (HDAC) Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Histone Deacetylase (HDAC) Inhibitors Market Size by Type
  2. 12.1.1 SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Histone Deacetylase (HDAC) Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA Histone Deacetylase (HDAC) Inhibitors Market Size by Application
  6. 12.2.1 SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Histone Deacetylase (HDAC) Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA Histone Deacetylase (HDAC) Inhibitors Market Size by Country
  10. 12.3.1 SAMEA Histone Deacetylase (HDAC) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Histone Deacetylase (HDAC) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Histone Deacetylase (HDAC) Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Histone Deacetylase (HDAC) Inhibitors Value Chain Analysis
  2. 13.1.1 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Histone Deacetylase (HDAC) Inhibitors Production Mode & Process
  6. 13.2 Histone Deacetylase (HDAC) Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Histone Deacetylase (HDAC) Inhibitors Distributors
  9. 13.2.3 Histone Deacetylase (HDAC) Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst